Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Biolase Inc (BIOL)

Biolase Inc (BIOL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 89,280
  • Shares Outstanding, K 151,194
  • Annual Sales, $ 22,780 K
  • Annual Income, $ -16,830 K
  • 60-Month Beta 1.59
  • Price/Sales 4.05
  • Price/Cash Flow N/A
  • Price/Book 2.76
Trade BIOL with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.36
  • Most Recent Earnings N/A on 08/13/21
  • Next Earnings Date 11/11/21
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend 0.010 on 06/24/05
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.03
  • Number of Estimates 1
  • High Estimate -0.03
  • Low Estimate -0.03
  • Prior Year -0.21
  • Growth Rate Est. (year over year) +85.71%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.5644 +2.75%
on 10/18/21
0.6950 -16.56%
on 09/23/21
-0.1101 (-15.96%)
since 09/17/21
3-Month
0.5500 +5.44%
on 08/04/21
0.9394 -38.27%
on 08/13/21
-0.0001 (-0.02%)
since 07/16/21
52-Week
0.2600 +123.04%
on 11/03/20
1.5100 -61.60%
on 01/26/21
+0.2699 (+87.06%)
since 10/16/20

Most Recent Stories

More News
BIOLASE To Host Q&A And Webcast For Investors Regarding Its Special Meeting Of Stockholders

/PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced it will host a Q&A session and webcast for investors...

BIOL : 0.5799 (-1.80%)
Quest Diagnostics' (DGX) Efforts to Reduce Health Inequities

Quest Diagnostics' (DGX) efforts to support AHA will boost innovative solutions like the Scholars programs, hypertension control and COVID-19 rapid response.

DGX : 143.72 (+0.86%)
ALC : 78.28 (+0.33%)
BIOL : 0.5799 (-1.80%)
WST : 408.72 (+0.97%)
Here's Why You Should Add STERIS (STE) to Your Portfolio

Investors are optimistic about STERIS (STE) owing to elevated consumer demand and rebound in procedure volumes and raised 2022 outlook.

MCK : 200.80 (-1.65%)
ALC : 78.28 (+0.33%)
BIOL : 0.5799 (-1.80%)
STE : 223.20 (-0.84%)
Hill-Rom (HRC) New LT Strategy Aids, Y/Y Comparisons Ail

Hill-Rom's (HRC) newly initiated long-term growth strategies through fiscal 2022, focusing on all four strategic priorities, look attractive at this moment.

MCK : 200.80 (-1.65%)
ALC : 78.28 (+0.33%)
BIOL : 0.5799 (-1.80%)
HRC : 150.75 (-0.17%)
Here's Why You Should Retain Haemonetics (HAE) Stock for Now

Investors are optimistic about Haemonetics (HAE) on strong demand for NexSys PCS system and potential of Hemostasis Management franchise.

MCK : 200.80 (-1.65%)
HAE : 67.07 (-4.06%)
ALC : 78.28 (+0.33%)
BIOL : 0.5799 (-1.80%)
Henry Schein (HSIC) Dental Sales Grow Globally Despite Pandemic

Widespread network and channel mix along with favorable long-term trends in the dental business bode well for Henry Schein (HSIC).

MCK : 200.80 (-1.65%)
HSIC : 76.53 (-1.18%)
ALC : 78.28 (+0.33%)
BIOL : 0.5799 (-1.80%)
Haemonetics (HAE) Rides on Plasma Arm Recovery Amid COVID Woes

Haemonetics' (HAE) hospital business is recovering primarily driven by continued improvement in hospital procedures.

MCK : 200.80 (-1.65%)
HAE : 67.07 (-4.06%)
ALC : 78.28 (+0.33%)
BIOL : 0.5799 (-1.80%)
QIAGEN (QGEN) to Boost NeuMoDx Production With US DOD Contract

QIAGEN's (QGEN) NeuMoDx platforms offer a unique combination of speed, flexibility, throughput and ease of use for molecular diagnostics testing, including laboratory-developed tests.

MCK : 200.80 (-1.65%)
ALC : 78.28 (+0.33%)
QGEN : 52.11 (+0.91%)
BIOL : 0.5799 (-1.80%)
Here's Why You Should Hold on to Thermo Fisher (TMO) for Now

Investors are optimistic about Thermo Fisher (TMO) on strength in end markets and raised 2021 guidance.

TMO : 588.03 (+0.97%)
MCK : 200.80 (-1.65%)
ALC : 78.28 (+0.33%)
BIOL : 0.5799 (-1.80%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Biolaw Technology, Inc. is the world's leading dental laser company, is a medical technology company that develops, manufactures and markets lasers and related products focused on technologies that advance the practice of dentistry and medicine. The Company's products incorporate patented and patent...

See More

Key Turning Points

3rd Resistance Point 0.6201
2nd Resistance Point 0.6058
1st Resistance Point 0.5929
Last Price 0.5799
1st Support Level 0.5657
2nd Support Level 0.5514
3rd Support Level 0.5385

See More

52-Week High 1.5100
Fibonacci 61.8% 1.0325
Fibonacci 50% 0.8850
Fibonacci 38.2% 0.7375
Last Price 0.5799
52-Week Low 0.2600

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar